Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05338060 · ClinicalTrials.gov registry record
A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer
A clinical trial, sponsored by Inova Health Care Services.
- Completed
- Registry status
- 10
- Enrollment target
NCT05338060: Completed study, sponsored by Inova Health Care Services.
NCT05338060 is a clinical trial that has completed, run by Inova Health Care Services. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05338060 has completed, sponsored by Inova Health Care Services.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this research is to collect surgical drain fluid and blood from patients who have undergone surgery for gastric or esophageal cancer, and to analyze the fluid and blood using a variety of laboratory techniques for molecular markers capable of predicting response to immunotherapy.
Primary Outcome
to establish a workflow for collection of SEs from patients affected by esophageal and gastric cancer undergoing surgical resection.
Interventions
- OTHER prospective collection of surgical exudates (SEs)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-01-26 |
| Est. Completion | 2025-08-05 |
What the finished NCT05338060 record still lists
NCT05338060 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which prospective collection of surgical exudates (SEs) is the first listed.
NCT05338060 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05338060 about?
NCT05338060 is a clinical study titled "A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer". The purpose of this research is to collect surgical drain fluid and blood from patients who have undergone surgery for gastric or esophageal cancer, and to analyze the fluid and blood using a variety of laboratory techniques for molecular markers capable of predicting response to immunotherapy.
What is the current status of trial NCT05338060?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2022-01-26. Estimated completion is 2025-08-05.
What interventions are being tested in trial NCT05338060?
The interventions under investigation include: prospective collection of surgical exudates (SEs) (OTHER).
Who is sponsoring clinical trial NCT05338060?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI